910 Clopper Road
United States - Map
GenVec, Inc. operates as a biopharmaceutical company that uses differentiated and proprietary technologies to create therapeutics and vaccines. The company develops its product candidates through collaborations with various companies and organizations, including Novartis AG, Merial Limited, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of various human and animal health concerns. Its development programs address various therapeutic areas, such as hearing loss and balance disorders; and vaccines against infectious diseases, including respiratory syncytial virus, herpes simplex virus, dengue fever, and malaria. The company is also involved in developing vaccines against foot-and-mouth disease in the area of animal health. It has a collaboration agreement with TheraBiologics to develop neural stem cell mediated cancer therapies. GenVec, Inc. was founded in 1992 and is based in Gaithersburg, Maryland.
|Mr. Douglas J. Swirsky CPA, CFA,
Chief Exec. Officer, Pres, Corp. Sec. and Director
|Dr. Douglas E. Brough Ph.D.,
Chief Scientific Officer
|Dr. Bryan T. Butman Ph.D.,
Sr. VP of Devel.
|Mr. James Vincent Lambert ,
Principal Financial Officer, Principal Accounting Officer, Sr. Director of Accounting & Fin., Treasurer and Corp. Controller
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|